Anuj Gaggar - 29 Mar 2025 Form 4 Insider Report for ASSEMBLY BIOSCIENCES, INC. (ASMB)

Reporting relationship: Chief Medical Officer
Issuer ticker: ASMB
Reported as of: 29 Mar 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 01 Apr 2025, 16:05:03 UTC
Prior SEC filing: 13 Nov 2023
Next SEC filing: 31 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ John O. Gunderson, as Attorney-in-Fact

Key filing fact

Anuj Gaggar filed Form 4 for ASSEMBLY BIOSCIENCES, INC. (ASMB) on 01 Apr 2025.

Key facts

This page summarizes Anuj Gaggar's Form 4 filing for ASSEMBLY BIOSCIENCES, INC. (ASMB).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 01 Apr 2025, 16:05.

Change

Previous filing in this sequence was filed on 13 Nov 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ASMB transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +24,200
Change %
Price: $0.000000
Shares after: 24,200
Date: 29 Mar 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 24,200
Exercise price: $10.62
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Grant of stock options. The stock options vest over four years, assuming continuous service on each vesting date, as follows: 25% vest on the first anniversary of the date of grant, March 29, 2026; and the remaining 75% vest in 36 approximately equal monthly installments, with the options becoming fully vested on March 29, 2029.